Literature DB >> 21262386

Identification of novel three allergens from Anisakis simplex by chemiluminescent immunoscreening of an expression cDNA library.

Yukihiro Kobayashi1, Kenichi Ohsaki, Kaori Ikeda, Seiko Kakemoto, Shoichiro Ishizaki, Kuniyoshi Shimakura, Yuji Nagashima, Kazuo Shiomi.   

Abstract

Anisakis simplex is a representative nematode parasitizing marine organisms, such as fish and squids, and causes not only anisakiasis but also IgE-mediated allergy. Although 10 kinds of proteins have so far been identified as A. simplex allergens, many unknown allergens are considered to still exist. In this study, a chemiluminescent immunoscreening method with higher sensitivity than the conventional method was developed and used to isolate IgE-positive clones from an expression cDNA library of A. simplex. As a result, three kinds of proteins, Ani s 11 (307 amino acid residues), Ani s 11-like protein (160 residues) and Ani s 12 (295 residues), together with three known allergens (Ani s 5, 6 and 9), were found to be IgE reactive. Furthermore, ELISA data showed that both recombinant Ani s 11 and 12 expressed in Escherichia coli are recognized by about half of Anisakis-allergic patients. Ani s 11 and Ani s 11-like protein are characterized by having six and five types of short repetitive sequences (5-16 amino acid residues), respectively. Both proteins share as high as 78% sequence identity with each other and also about 45% identity with Ani s 10, which includes two types of short repetitive sequences. On the other hand, Ani s 12 is also structurally unique in that it has five tandem repeats of a CX(13-25)CX(9)CX(7,8)CX(6) sequence, similar to Ani s 7 having 19 repeats of a CX(17-25)CX(9-22)CX(8)CX(6) sequence. The repetitive structures are assumed to be involved in the IgE-binding of the three new allergens.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21262386     DOI: 10.1016/j.parint.2011.01.004

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  7 in total

Review 1.  New Perspectives on the Diagnosis of Allergy to Anisakis spp.

Authors:  Ignacio Moneo; Noelia Carballeda-Sangiao; Miguel González-Muñoz
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

2.  Identification and Preliminary Evaluation of a Novel Recombinant Protein for Serodiagnosis of Strongyloidiasis.

Authors:  Norsyahida Arifin; Muhammad Hafiznur Yunus; Thomas J Nolan; James B Lok; Rahmah Noordin
Journal:  Am J Trop Med Hyg       Date:  2018-02-08       Impact factor: 2.345

3.  A 24 kDa excretory-secretory protein of Anisakis simplex larvae could elicit allergic airway inflammation in mice.

Authors:  Hye-Kyung Park; Min Kyoung Cho; Mi Kyung Park; Shin Ae Kang; Yun Seong Kim; Ki Uk Kim; Min Ki Lee; Mee Sun Ock; Hee Jae Cha; Hak Sun Yu
Journal:  Korean J Parasitol       Date:  2011-12-16       Impact factor: 1.341

Review 4.  Excretory/secretory products of anisakid nematodes: biological and pathological roles.

Authors:  Foojan Mehrdana; Kurt Buchmann
Journal:  Acta Vet Scand       Date:  2017-06-23       Impact factor: 1.695

Review 5.  Helminth Allergens, Parasite-Specific IgE, and Its Protective Role in Human Immunity.

Authors:  Colin Matthew Fitzsimmons; Franco Harald Falcone; David William Dunne
Journal:  Front Immunol       Date:  2014-02-14       Impact factor: 7.561

Review 6.  Advances in Omic Studies Drive Discoveries in the Biology of Anisakid Nematodes.

Authors:  Stefano D'Amelio; Fabrizio Lombardo; Antonella Pizzarelli; Ilaria Bellini; Serena Cavallero
Journal:  Genes (Basel)       Date:  2020-07-15       Impact factor: 4.096

7.  Quantitative Proteomics Comparison of Total Expressed Proteomes of Anisakis simplex Sensu Stricto, A. pegreffii, and Their Hybrid Genotype.

Authors:  Susana C Arcos; Lee Robertson; Sergio Ciordia; Isabel Sánchez-Alonso; Mercedes Careche; Noelia Carballeda-Sanguiao; Miguel Gonzalez-Muñoz; Alfonso Navas
Journal:  Genes (Basel)       Date:  2020-08-10       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.